Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 30.83 USD -3.05% Market Closed
Market Cap: 855.2m USD
Have any thoughts about
Castle Biosciences Inc?
Write Note

Castle Biosciences Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Castle Biosciences Inc
Accounts Payable Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Castle Biosciences Inc
NASDAQ:CSTL
Accounts Payable
$6.8m
CAGR 3-Years
34%
CAGR 5-Years
39%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Accounts Payable
$488.2m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
1%
Quest Diagnostics Inc
NYSE:DGX
Accounts Payable
$1.3B
CAGR 3-Years
-7%
CAGR 5-Years
4%
CAGR 10-Years
2%
CVS Health Corp
NYSE:CVS
Accounts Payable
$54.9B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
17%
Cigna Corp
NYSE:CI
Accounts Payable
$8.5B
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
5%
Laboratory Corporation of America Holdings
NYSE:LH
Accounts Payable
$660.9m
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
9%

See Also

What is Castle Biosciences Inc's Accounts Payable?
Accounts Payable
6.8m USD

Based on the financial report for Sep 30, 2024, Castle Biosciences Inc's Accounts Payable amounts to 6.8m USD.

What is Castle Biosciences Inc's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
39%

Over the last year, the Accounts Payable growth was -1%. The average annual Accounts Payable growth rates for Castle Biosciences Inc have been 34% over the past three years , 39% over the past five years .

Back to Top